Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN968991 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) antibody
- Antibody type
- Monoclonal
- Description
- Ascites
- Reactivity
- Human, Mouse
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 1H12
- Vial size
- 100 μL
- Storage
- 4°C, -20°C for long term storage
Submitted references Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane.
Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Dec 10;26(35):5705-12
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Dec 10;26(35):5705-12
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane.
Riesco-Eizaguirre G, Gutiérrez-Martínez P, García-Cabezas MA, Nistal M, Santisteban P
Endocrine-related cancer 2006 Mar;13(1):257-69
Endocrine-related cancer 2006 Mar;13(1):257-69
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ICC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
